While shares in Computershare (ASX: CPU) fired up in response to the release of its fiscal 2016 result yesterday, analysts have responded in a mixed fashion with Bell Potter maintaining a sell recommendation on the stock while Morgans CIMB upgraded its recommendation from hold to add.
There is a stark disparity between the broker’s share price targets. Lafitani Sotiriou from Bell Potter maintained his price target at $7.50, while Morgans’ Richard Coles increased his price target from $10.41 to $10.82. Under high-volume trading, shares in Computershare surged yesterday, increasing from the previous day’s close of $8.95 to hit an intraday high of $10.17 before closing at $9.74.
Coles noted that fiscal 2016 earnings per share (US54.7 cents) were slightly above his estimate of US53.8 cents per share. However, Sotiriou focused on the lack of growth within the business and the likelihood that this will continue despite the group having made numerous acquisitions in recent years.
While acknowledging the net profit was 2.2% ahead of his estimates, Sotiriou also noted that the year-on-year earnings per share decline of 7.9% was slightly higher than management’s guidance of a 7.5% downturn.
Bell Potter is forecasting an adjusted net profit of US$290 million in fiscal 2017, representing earnings per share of AUD71.9 cents. This implies a fiscal 2017 PE multiple of 13.5, well below the heady multiples of circa 20 that the company consistently traded on some years back.
However, it would appear those days are over with Bell Potter forecasting earnings per share to decline 5% in fiscal 2017, but of more concern, not recapture 2016 levels before fiscal 2020.
On this basis, Bell Potter’s sell recommendation and a price target that implies a PE multiple of approximately 10 appears in keeping with the stock’s prospects.
Investors should note that broker forecasts, as well as share price targets and fluctuations are fluid and investors should take a cautious approach to any investment decision, and in particular not base that decision solely on the financial metrics of the company and its peers.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.